NorthWest Biotherapeutics Inc (NWBO)

[notbrad]

Some closing thoughts to taunt the shorts:

Point 1:
Potential market in US: 30,000 patients
Let's say market penetration by 2020: 50%
Price per treatment: $120K
Revenues: $1.8B in US alone.
Ex-US: add 50%
Total revenue: $2.7B (for GBM)

Current sales multiples for cell therapies: 7 times revenues for 2020 estimates.
Market cap: 18.9B
Share price: $20.32

If you own 50,000 shares, value = $1,016,000
If you own 100,000 shares, value = 2,032,000

Point 2:
CAR-T therapies are being approved with phase 2 results.
DCVax-Direct + Keytruda will show blow out results.
2019 top line; 2020 approval.
Make your own estimates on the revenues :)
Have a good night.